Dr. Jesus Blanco M.D.

Recommended Articles

• Is Ibuprofen the Secret to Cystic Fibrosis Treatment?

  Scientists say yes. The drug that works wonders for so many other everyday ailments could be a key component in the future treatments of cystic fibrosis patients. It’s hard to imagine that a drug found in nearly everyone's medicine cabinet could be a crucial component in the treatment of cystic...

• What Are the Common Lung Irritants Found at Home?

  Traffic exhaust or second hand smoke are sure to trigger a number of lung issues, particularly if you are susceptible to respiratory disorders. However, there are a number of very common, yet hidden, triggers in one's household that can lead to symptoms of asthma and other respiratory ailments.There...

• Cystic Fibrosis: Talking to Loved Ones

  When getting a life-changing diagnosis, it may be hard to discuss it with others. It is isolating when you feel others do not understand; your family and friends may not have cystic fibrosis or know people affected by the disease. You may also be dealing with shock from the new diagnosis. Chances...

• What to Do if You Have a Lung Injury

  For the past several years, lung injuries have remained one of the most common cases to be noted in the emergency units of several hospitals. There are different types of lung injuries that require medical attention as soon as possible. There are different ways by which a person may end up with a...

• What Is Emphysema? Home Remedies for Emphysema Patients

  Emphysema is a form of chronic lung disease and one of the main types of chronic obstructive pulmonary disease (COPD). This disease is regarded as "obstructive" because people who are suffering from emphysema exhale air as if there is an obstruction. There are various factors that can cause...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...